Optimal two‐stage designs for clinical trials with binary response
- 1 May 1988
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 7 (5) , 571-579
- https://doi.org/10.1002/sim.4780070504
Abstract
We present a simple two-stage design for a randomized clinical trial with dichotomous outcomes. It is based on a design of Ellenberg and Eisenberger which permits early acceptance of the null hypothesis after the first stage. We have optimized the design by minimizing the average expected sample size subject to constraints on the type 1 and type 2 errors. The resulting designs have maximum sample size only slightly larger than that of single stage trial, with 40–45 per cent of this maximum allocated to the first stage, and null hypothesis probability of early acceptance in excess of 0.60.Keywords
This publication has 20 references indexed in Scilit:
- Asymmetric group sequential boundaries for monitoring clinical trialsBiometrika, 1982
- On choosing the number of interim analyses in clinical trialsStatistics in Medicine, 1982
- Group sequential methods for clinical trials with a one-sided hypothesisBiometrika, 1980
- Mlab — A mathematical modeling toolComputer Programs in Biomedicine, 1979
- Two-Stage Plans Compared with Fixed-Sample-Size and Wald SPRT PlansJournal of the American Statistical Association, 1976
- Some Reasons for Not Using the Yates Continuity Correction on 2 × 2 Contingency TablesJournal of the American Statistical Association, 1974
- Nonlinear Regression With Linear Constraints: An Extension of the Magnified Diagonal MethodJournal of the ACM, 1970